Owens & Minor (NYSE:OMI) Updates Q4 2024 Earnings Guidance

Owens & Minor (NYSE:OMI) issued an update on its fourth quarter 2024 earnings guidance on Monday morning. The company provided earnings per share guidance of 0.520-0.550 for the period, compared to the consensus earnings per share estimate of 0.530. The company issued revenue guidance of $2.7 billion-$2.7 billion, compared to the consensus revenue estimate of $2.7 billion. Owens & Minor also updated its FY 2024 guidance to 1.500-1.530 EPS.

Analysts Set New Price Targets

OMI has been the topic of several recent analyst reports. Barclays cut their price objective on shares of Owens & Minor from $18.00 to $14.00 and set an “equal weight” rating on the stock in a research report on Tuesday, November 5th. Citigroup decreased their target price on shares of Owens & Minor from $21.00 to $18.50 and set a “buy” rating on the stock in a research note on Tuesday, November 5th. Robert W. Baird reduced their target price on Owens & Minor from $19.00 to $14.00 and set a “neutral” rating for the company in a report on Tuesday, November 5th. Finally, UBS Group reduced their price objective on shares of Owens & Minor from $28.00 to $25.00 and set a “buy” rating on the stock in a research note on Tuesday, November 5th. Two equities research analysts have rated the stock with a sell rating, five have given a hold rating and two have given a buy rating to the company. According to MarketBeat.com, Owens & Minor presently has an average rating of “Hold” and a consensus price target of $18.50.

Owens & Minor Stock Down 35.2 %

OMI opened at $9.23 on Tuesday. The stock’s fifty day moving average is $13.77 and its two-hundred day moving average is $14.28. The company has a debt-to-equity ratio of 2.11, a quick ratio of 0.45 and a current ratio of 1.09. Owens & Minor has a 52 week low of $8.76 and a 52 week high of $28.35.

Owens & Minor (NYSE:OMI) last announced its quarterly earnings data on Monday, November 4th. The company reported $0.42 earnings per share for the quarter, beating analysts’ consensus estimates of $0.41 by $0.01. Owens & Minor had a negative net margin of 0.46% and a positive return on equity of 14.60%. The business had revenue of $2.72 billion for the quarter, compared to analyst estimates of $2.68 billion. During the same period last year, the business earned $0.44 EPS. The company’s revenue was up 5.0% on a year-over-year basis. As a group, analysts predict that Owens & Minor will post 1.49 earnings per share for the current fiscal year.

Insider Transactions at Owens & Minor

In other Owens & Minor news, CFO Jonathan A. Leon sold 5,282 shares of the business’s stock in a transaction dated Thursday, November 21st. The shares were sold at an average price of $11.82, for a total value of $62,433.24. Following the completion of the transaction, the chief financial officer now directly owns 130,822 shares of the company’s stock, valued at approximately $1,546,316.04. The trade was a 3.88 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 2.62% of the company’s stock.

About Owens & Minor

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.